Kesoram Industries Share Price
10.88-0.18 (-1.63%)
+109.63% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Kesoram Industries Share Price
10.88-0.18 (-1.63%)
+109.63% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Kesoram Industries Share Price
10.88-0.18 (-1.63%)
+109.63% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
Kesoram Industries Share Price
10.88-0.18 (-1.63%)
+109.63% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Kesoram Industries Share Price
10.88-0.18 (-1.63%)
+109.63% past 1 Year
Corporate filings & documents

No corporate filings & documents found
Kesoram Industries Share Price
10.88-0.18 (-1.63%)
+109.63% past 1 Year
News
PM Modi Highlights Strength And Resilience Of India Banking System
Broader Market
High Court Orders SpiceJet To Pay Rs 145 Crores In Maran Case
Equity
500285
IFSCA Plans Commodity Trading Support At GIFT City To Attract Foreign Investors
Equity
MCX
PM Modi Highlights Power Of Helping Others Progress Forward
Broader Market
PM Modi Highlights Affordable Digital Access and India’s Global South Leadership
Broader Market
Mankind Pharma Sees Rs 46.93 Crores BSE Block Trade In 196108 Shares
Equity
MANKIND
PM Modi Calls For Power To Empower Enable And Collaborate
Broader Market
PM Modi Highlights Technology Innovation And Data As Growth Drivers
Broader Market
PFC Reports Rs 294.27 Crores BSE Block Trade At Rs 335.20
Equity
PFC
PFC Reports Rs 341.63 Crores NSE Block Trade At Rs 334.65
Equity
PFC
Kotak Mahindra Bank Records Rs 22.88 Crore NSE Block Trade
Equity
KOTAKBANK
Max Healthcare Reports Rs 25.74 Crores BSE Block Trade At Rs 857.20
Equity
MAXHEALTH
Zydus Lifesciences Seeks Approval To Expand Affordable Pembrolizumab Access
Equity
ZYDUSLIFE
Zydus Lifesciences Reports Strong Keytruda Global Sales And Revenue Contribution
Equity
ZYDUSLIFE
Zydus Lifesciences FYB206 Becomes First Keytruda Biosimilar Accepted For USFDA Review
Equity
ZYDUSLIFE
RBL Bank Targets Sustained Loan Growth After Capital And FCNR B Mobilisation
Equity
RBLBANK
Shyam Metalics Gains Fuel Security Through Phutamura Coal Block Acquisition
Equity
SHYAMMETL
TD Power Systems Raises Rs 600 Crores Through Qualified Institutions Placement
Equity
TDPOWERSYS
Kolte Patil Developers Reports Strong Q2 FY24 Collection Growth
Equity
KOLTEPATIL
HCLTech Raises FY27 Revenue Growth Guidance Floor, Retains EBIT Margin Outlook
Equity
HCLTECH

